Trial-by-trial variability in local field potential (LFP), tissue partial pressure of oxygen (PO 2 ), cerebral blood flow (CBF), and deoxyhemoglobin-weighted optical imaging of intrinsic signals (OIS) were tested in the rat somatosensory cortex while fixed electrical forepaw stimulation (1.0-ms pulses with amplitude of 1.2 mA at a frequency of 6 Hz) was repeatedly applied. The changes in the cerebral metabolic rate of oxygen (CMRO 2 ) were also evaluated using a hypotension condition established by our group based on the administration of a vasodilator. Under normal conditions, CBF, PO 2 , and OIS showed positive signal changes (48%, 32%, and 0.42%, respectively) following stimulation. Over multiple trials, the CBF responses were well correlated with the integral of the LFP amplitudes (∑LFP) (R mean = 0.78), whereas a lower correlation was found between PO 2 and ∑LFP (R mean = 0.60) and between OIS and ∑LFP (R mean = 0.54). Under the hypotension condition the LFP responses were preserved, but the CBF responses were suppressed and the PO 2 and OIS changes were negative (−12% and −0.28%, respectively). In this condition, the trial-by-trial variations in PO 2 and OIS were well correlated with the variability in ∑LFPs (R mean = −0.77 and −0.76, respectively), indicating a single trial coupling between CMRO 2 changes and ∑LFP. These findings show that CBF and CMRO 2 signals are more directly correlated with neural activity compared to blood oxygen-sensitive methods such as OIS and BOLD fMRI.
Introduction
Since fMRI measures neural activity-induced changes in physiologic processes, i.e., local cerebral blood flow (CBF) and cerebral metabolic rate of oxygen (CMRO 2 ), understanding the direct relationship between the fMRI signal and neural activity is fundamental. Interestingly, the variability in fMRI signals is relatively high even during repetition of simple tasks (Tegeler et al., 1999; Waldvogel et al., 2000) . Many of these sources of variability are undesirable including some which are of physiologic origin, such as cardiac and respiratory fluctuations (Hu et al., 1995; Glover et al., 2000) . In addition, the physiological baseline state has also been shown to impact the amplitude and shape of the BOLD fMRI response (Cohen et al., 2002) . Recent studies have also shown that trial-by-trial fMRI can allow the measurement of trial-by-trial fluctuations in neural activity (Eichler, 2005; Debener et al., 2005) . For example, slow fluctuations in the fMRI signal have been used to map known brain systems (e.g., sensory) in the absence of stimulation (Biswal et al., 1995) , and they have been shown to be linearly superimposed with stimulation-related responses (Fox et al., 2006) . Simultaneous EEG and fMRI studies strongly suggest that a significant or at least measurable amount of variability also stems from stimulus-related neural activities. To validate the capability of trial-by-trial fMRI measurements to encode trial-by-trial variations in neural responses, it is important to investigate how these variabilities translate through the principal pathways of the hemodynamic response, namely neuro-metabolic (CMRO 2 ) and neuro-vascular (CBF) coupling.
Optical imaging of intrinsic signals (OIS) can measure deoxyhemoglobin-weighted changes (Frostig et al., 1990; Malonek and Grinvald, 1996) , and can be combined with recordings of electrical activity and tissue oxygen tension with relative ease compared to BOLD fMRI. It has been shown that the spatial specificity of deoxyhemoglobin-weighted OIS induced by neural activity (i.e., the increase in light reflectance) coincides with that of BOLD responses (Kennerley et al., 2005) , suggesting that deoxyhemoglobin-weighted OIS can be used as a BOLD analogue. To test the variability in CMRO 2 induced by neural activity, our laboratory adapted a vasodilator-induced hypotension model in which the vascular response to neural activity is specifically suppressed (Nagaoka et al., 2006) . In that study, the cerebral blood volume (CBV) and BOLD fMRI responses to visual stimulation were measured and typical positive responses (i.e., increase in BOLD signal and CBV) were reported under control conditions. After infusion of the vasodilator sodium nitroprusside, the CBV response was suppressed and the BOLD fMRI response was negative. In another study by Fukuda et al., spiking activity and deoxyhemoglobin-weighted OIS were measured in response to visual stimulation under control and hypotension conditions in the anesthetized cat and the neural response was shown to be preserved under the hypotension condition (Fukuda et al., 2006) . Similarly, OIS showed activity-induced decreases in intensity (i.e., increase in light absorption), indicating that it predominantly represents the dynamic CMRO 2 changes. By measuring the tissue partial pressure of oxygen (PO 2 ), the absolute changes in CMRO 2 can be determined from hypotension condition measurements. Further, the dynamic measurement of CMRO 2 change can be compared with the dynamic changes in CBF obtained from control condition measurements in the same subject. This direct comparison allows the investigation of a neurovascular mechanism issue, which is whether the increases in CBF are controlled by elevations in CMRO 2 .
In the present study, single-trial neuro-metabolic and neurovascular couplings were directly measured using an oxygen microelectrode, laser-Doppler flowmetry (LDF), and OIS concurrently performed with LFP recordings in the anesthetized rat somatosensory cortex. Fixed forepaw stimulation was repeatedly applied under normal (control) and vasodilator-induced hypotension conditions. The dynamic CMRO 2 change was evaluated from the hypotension condition data obtained in the same subject. In summary, we found that trial-by-trial variations in CMRO 2 , CBF and oxygenation level changes are all well correlated with trial-bytrial variations in LFP changes.
Materials and methods

Animal preparation
Six male Sprague-Dawley rats (400 to 560 g; Charles River Laboratories, Wilmington, MA) were used with experimental protocols approved by the University of Pittsburgh Institutional Animal Care and Use Committee in accordance with the standards for humane animal care and use as set by the Animal Welfare Act and the NIH Guide for the Care and Use of Laboratory Animals. The animals were anesthetized with isoflurane (5% for induction and 1.5% to 2% during surgery) via a vaporizer with a mixture of O 2 (35% to 50%) and N 2 O (50% to 65%). Endotracheal intubation was performed, and catheters were placed into the femoral vein and artery. Minute ventilation volume and respiratory rate were adjusted with a ventilator (TOPO™, Kent Scientific Corp., Torrington, CT). Arterial blood sampling was periodically performed to measure systemic arterial blood PO 2 (PaO 2 ), PCO 2 (PaCO 2 ), pH, and hemoglobin concentrations (Hb) with a blood gas analyzer (Stat Profile ® , Nova Biomedical Corporation, Waltham, MA). Systemic arterial blood pressure, heart rate, and respiratory parameters were monitored with polygraph dataacquisition software (AcqKnowledge, BIOPAC systems, Inc., Goleta, CA). Rectal temperature was maintained at 37.0°C with a DC temperature control module (40-90-8C, FHC, Inc., Bowdoinham, ME).
The animal was placed in a stereotaxic frame (Narishige International USA, Inc., East Meadow, NY), and an area (5 mm × 7 mm) on the left skull, centered at 3.5 mm lateral and 0.5 mm rostral from the Bregma (Hall and Lindholm, 1974) , was thinned with a drill to make a thinned skull preparation (Lindauer et al., 1993) . After the completion of the animal preparation, the inspired gas was converted to a mixture of air and O 2 (30% to 35% total O 2 ) and the end-tidal isoflurane concentration was adjusted to 1.3 ± 0.1% (Antognini et al., 1999; Masamoto et al., 2007a) . At first, preliminary mapping with OIS (pre-mapping) was performed for the localization of the forepaw area in the primary somatosensory cortex. Based on this OIS map, the probes were arranged. The concurrent recordings of LFP, CBF, PO 2 , and OIS were then performed. The vasodilator drug was intravenously injected, and the same experiment was duplicated under vasodilator-induced hypotension conditions. In some animals (N = 3), multiple sets of control and hypotension experiments were repeatedly conducted to increase the number of trials.
Forepaw stimulation
Two needle electrodes were inserted between digits two and four of the right forepaw (Silva et al., 1999) . Electrical pulse stimulation (1.0 ms pulse width, 1.2 mA current) was applied with a pulse generator and isolator (Master 8 and ISO-Flex, A.M.P.I, Israel). For pre-mapping, twenty runs of forepaw stimulation were performed with stimulus duration of 3 sec and frequency of 3 Hz with an inter-run time of 6 sec. For the remaining experiments, ten to sixty runs of forepaw stimulation were performed with stimulus duration of 10 sec and frequency of 6 Hz with an interrun time of 80 sec. The stimulation protocol was previously refined to induce robust LFP, CBF, and BOLD responses (Masamoto et al., 2007a) .
Hypotension condition
Sodium-nitroprusside (0.5 mg/ml in saline), a rapid-acting vasodilator, was used to suppress the vascular responses to neural activity (Fukuda et al., 2006; Nagaoka et al., 2006) . Its pharmacological action is principally the relaxation of vascular smooth muscle, leading to a dilation of peripheral arteries and veins, and a consequent decrease in the arterial blood pressure (Auer, 1978; Roos et al., 1994) . While the drug was continuously injected (0.03 to 0.11 ml/min, i.v.), the mean arterial blood pressure was stabilized between 35 and 45 mm Hg. The recording commenced about 2 min after onset of injection. Upon completion of the recordings (∼ 20 min), the drug administration was terminated. The total dosage was 2.2 ± 0.6 mg/kg (N = 6).
Pre-mapping
For localization of the forepaw area in the primary somatosensory cortex, deoxyhemoglobin-weighted OIS was performed with the irradiation of 620 ± 10 nm filtered light. The field of view was 4.9 mm × 3.7 mm and the matrix size was 320 × 240 after spatial binning of 2 × 2 pixels. The images were acquired at 30 frames per second and 15 consecutive frames (0.5 sec) were averaged during off-line analysis. The average of two pre-stimulation images was used as the control image (R) and the average of four images (from 0.5 sec to 2.5 sec) after the onset of stimulation was used as the activation image (R′). The activation focus was determined to be the area surrounding the largest decrease in light reflectance in the map (Narayan et al., 1994; Nemoto et al., 2004; Masamoto et al., 2007a) .
Simultaneous recordings of LFP, CBF, PO2, and OIS
The LFP and PO 2 were simultaneously recorded with a doublebarrel type microelectrode: a Clark-type electrode for oxygen measurements and a platinum electrode for neural activity measurements (APOX, Unisense A/S, Aarhus N, Denmark). The electrode tip (30 μm outside diameter) was positioned at a depth of about 0.3 mm from the cortical surface on the activation focus (Masamoto et al., 2007a,b) . The oxygen electrode was calibrated before and after each experiment with 0%, 21%, and 100% oxygen in saline solution (37°C). The CBF around the activation focus was measured with a laser-Doppler flowmetry system (LDF; PeriFlux 4001Master, Perimed, Sweden) equipped with a needletype probe (Probe 411, Perimed, Sweden). The probe was placed on the surface of the thinned skull covering the activation focus (see Fig. 1 ). Based on the OIS-determined activation area ( Fig. 1 , left; dark pixels indicate an increase in light absorption due to an increase in deoxy-hemoglobin), the dual-barrel microelectrode and LDF probe were positioned within 0.5 mm of each other (Fig. 1, right) . The time constant of LDF system was 0.03 sec. The LFP, PO 2 , and LDF signals were recorded on a PC with BIOPAC data-acquisition software (AcqKnowledge, BIOPAC systems, Inc., Goleta, CA) at a rate of 1 kHz. OIS was also simultaneously performed at a rate of 30 frames per sec, as described above (see Pre-mapping).
Data processing
Among the six animals studied, five animals were studied using the same dual-barrel microelectrode, and the remaining animal was not. Due to different electrode sensitivities, this specific animal was not included in the population analysis. All population data are reported as mean ± SD (N = 5), unless otherwise specified. All the data processing was performed using Matlab (Mathworks Inc, Natick, MA).
For each trial, the LFP amplitude responding to each individual stimulation pulse was measured by the difference in amplitude between the negative peak and the positive peak observed within 20 ms after each stimulus. Then, the LFP amplitudes of all 60 pulses were summed to obtain the integrated LFP response of each trial (∑LFP) (Masamoto et al., 2007a) . To examine the variations in LFP responses, the coefficient of variance (CV) was determined for the each individual LFP amplitude (pulses #1 to #60 in a pulse train) across all trials in each subject. LDF (CBF), PO 2 , and OIS data were then downsampled to 5 Hz (i.e., 5 samples per second) by averaging consecutive data points to improve the signal-tonoise ratio. The OIS time series data were obtained from a 0.5 mm × 0.5 mm region of interest (ROI) centered on the activation focus (Fig. 1) for comparison with the LFP, CBF and PO 2 , data. The size of the ROI was selected in order to approximately cover the response volume of the PO 2 and LDF measurements. The fractional changes in CBF and OIS were calculated by the Fig. 1 . OIS map and ROI selection for simultaneous recordings of LFP, PO 2 , CBF, and OIS. A double-barrel type electrode (used to record LFP and PO 2 ) and LDF probe were placed at the activation focus (left) determined by mapping the forepaw area of rat somatosensory cortex using OIS (premapping). The electrode tip was positioned at a depth of ∼ 0.3 mm from the cortical surface (right) and around the center of the LDF detection volume (∼ 1 mm 3 ). The position of the electrode and the LDF probe was within 0.5 mm of each other (right). The OIS time-series data were calculated by averaging the intensity over a 0.5 mm × 0.5 mm region of interest (ROI; within the red square) centered at the activation focus (scale bar = 0.5 mm). difference between activation and baseline data divided by the baseline data, while absolute PO 2 changes were determined by subtracting the baseline data from the activation data. The baseline data was defined as the average over 3 sec prior to the stimulation onset. Similarly, the stimulation data was defined as the mean of 3-sec period around the response maxima; specifically, 6-9 sec, 8-11 sec, and 6-9 sec after stimulation onset for the CBF, PO 2 , and OIS data under the control condition, and 6-9 sec, 9-12 sec, and 8-11 sec for the CBF, PO 2 , and OIS under the hypotension condition, respectively. Trial-by-trial changes in CBF, PO 2 , and OIS were then compared with corresponding ∑LFP data using linear regression within each subject tested. The significance of the slope being different from zero was assessed and reported using a t-test (their appropriate correlation coefficient was also calculated). Finally, a paired t-test was performed to compare the correlation results from the two experimental conditions performed in each subject.
The CBF, PO 2 , and OIS time courses were then averaged across all trials for each experiment in individual subjects to examine their dynamic properties. The time-to-% peak was determined as the time it takes for the signal to reach 10%, 50%, 90%, and 100% of the peak amplitude, except for CBF under the hypotension since there was no detectable response peak in this condition.
Results
Neural and vascular responses under control and hypotension conditions
No significant differences in the arterial blood conditions were observed between control and vasodilator-induced hypotension conditions (pH = 7.465 ± 0.017 and 7.454 ± 0.018, PaCO 2 = 39 ± 2 and 38 ± 3 mm Hg, PaO 2 = 114 ± 11 and 114 ± 13 mm Hg, and Hb = 13 ± 1 and 13 ± 1 g/dl, respectively, N = 6 animals). Thus, we can compare data obtained during normal and hypotension conditions. Typical time-series of mean arterial blood pressure, LFP and CBF were compared between control and hypotension conditions in one representative animal ( Figs. 2A-C) . A robust increase in CBF was observed under normal blood pressure conditions (∼ 92 mm Hg), while the CBF response was suppressed under the vasodilator-induced low blood pressure condition (∼ 44 mm Hg). However, no detectable difference in LFP activity was observed between control and hypotension conditions (Fig.  2B) . Therefore, the neuro-vascular coupling in the normal condition can be directly compared with the neuro-metabolic coupling in the hypotension condition. Fig. 3 . Group -averaged temporal dynamics. Temporal dynamics of CBF (A), PO 2 (B), and OIS (C) compared between control (red) and hypotension (blue) conditions. The signal was normalized by baseline (10-sec pre-stimulation data), and fixed forepaw stimulation (10 sec, gray shade) was repeatedly applied. For better visualization, error bars (S.D.) are shown in only one side. (D) Normalized temporal dynamics of averaged OIS under control conditions (red), OIS under hypotension conditions (blue), and CBF under control conditions (green) compared. The signal was normalized by its peak point, and the magnitude of the OIS hypotension data is presented for easier comparison. Note that CBF and OIS-control signals peaked earlier than the OIS-hypotension signal.
Group-averaged CBF, PO2, and OIS responses
Averaged time courses of CBF, PO 2 , and OIS are shown in Figs. 3A-C, and the magnitude of functional signal changes is shown in Table 1 . During the control experiments, functional CBF, PO 2 and OIS signals increased by 48 ± 23%, 32 ± 12%, and 0.42 ± 0.29%, respectively. In contrast, under the hypotension condition, both PO 2 and OIS decreased by 12 ± 9% and 0.28 ± 0.29%, respectively, while the CBF change was negligible (2 ± 2%). These results indicate that the PO 2 and OIS changes under hypotension conditions were predominantly induced by a functional CMRO 2 increase. Note that the baseline PO 2 , OIS (i.e., light reflectance), and CBF (LDF) were 47 ± 43% higher, 1.5 ± 2.0% lower, and 35 ± 18% higher under hypotension conditions compared to the respective control levels, which are due to vasodilator-induced effects. For OIS measurements, the temporal response obtained from a larger ROI was also examined (e.g., 2.0 mm × 2.0 mm), but the OIS time course was not significantly different from that of the selected ROI (data not shown), indicating that the functional response covered a sizable region.
Dynamics of CBF, PO2, and OIS signals
The group time-to-% peak data are summarized in Table 2 . The dynamic changes in CBF and CMRO 2 can be visualized by the normalized LDF and OIS time courses under normal and hypotension conditions, respectively, plotted in Fig. 3D . The CBF response under normal conditions peaked earlier than the apparent changes in CMRO 2 as represented by OIS (Fig. 3D) . The time-to-10% peak for the CBF response under control conditions was observed to be 0.9 ± 0.3 sec, while that of the OIS signal under hypotension conditions was 0.6 ± 0.4 sec. However, the CBF response peaked 7.8 ± 1.8 sec after the stimulation onset, whereas the OIS response under hypotension conditions peaked 9.1 ± 1.4 sec after stimulation onset (Fig. 3D) . Corresponding to this result, the peak of the positive OIS change under control conditions was observed to occur earlier than that in the hypotension condition (Fig. 3D) . It is worth noting that although the timecourses for the OIS and PO 2 responses were very similar (Figs. 3B and C), a relative lag of 1.4 ± 0.6 sec and 1.5 ± 1.3 sec was observed under control and hypotension conditions, respectively (Table 2) . This difference is likely due to the temporal characteristics of different recording systems.
Trial-by-trial correlations
Variation of the ∑LFP was significant even within subjects. The CV of the LFP response to pulse #1 ranged 0.1-0.3 across the trials. In contrast, the rest of the LFP responses (pulse #2 to #60) showed a higher level of variations (CV = 0.3-0.7). We observed that the correlation analysis was not biased against the temporal integration of LFP (data not shown). Thus, ∑LFP was used for comparison with hemodynamic and metabolic responses.
In single-trial basis, the response magnitude of CBF, PO 2, and OIS also varied under either control or hypotension conditions (Fig. 4) . The correlation analysis performed between the measured ∑LFP and CBF data on a trial-by-trial basis showed that the trialbasis variations were strongly correlated in all subjects under control conditions (t = 2.14 to 12.91, R = 0.53 to 0.92, p b 0.05 to 0.0001, Fig. 5A ). In contrast, a lower correlation was found between ∑LFP and PO 2 (t = − 0.71 to 9.02 to R = − 0.08 to 0.86, p b 0.10 to 0.0001, Fig. 5B ) and between ∑LFP and OIS under control conditions (t = 0.70 to 4.93, R = 0.20 to 0.81, p b 0.50 to 0.005, Fig. 5C ). Under hypotension conditions, a strong linear correlation between ∑LFP and PO 2 was found (t = − 2.23 to − 10.39, R = − 0.68 to − 0.95, p b 0.05 to 0.0001, Fig. 5D) . Similarly, the OIS data showed reasonably good correlation with ∑LFP (t = − 2.23 to − 7.34, R = − 0.54 to −0.90, p b 0.05 to 0.0001, Fig. 5E ). These results indicate that the variability in the CBF response and the apparent changes in CMRO 2 were well correlated with the trial-by-trial variations in ∑LFP.
A paired analysis between the R-score of the ∑LFP vs. OIS under control and hypotension conditions (R mean = 0.54, p mean b 0.11 and R mean = − 0.76, p mean b 0.15, respectively) determined that the correlation of the data under hypotension conditions was significantly improved (p b 0.05). The ∑LFP vs. PO 2 under control and hypotension conditions (R mean = 0.60, p mean b 0.10 and R mean = − 0.77, p mean b 0.01, respectively) revealed similar results but with lower significance (p b 0.10). These analyses indicate that CMRO 2 changes are more directly correlated with single trial-basis ∑LFP compared to oxygen-sensitive signals under normal conditions (BOLD). In terms of the neural correlation with CBF vs. CMRO 2 , 48 ± 23 2 ± 2 32 ± 12 − 12 ± 9 0.42 ± 0.29 − 0.28 ± 0.29 ⁎ Significant differences (paired t-test) between baseline and activation data (P b 0.01). Table 2 Time-to-% peak of CBF, PO 2 , and OIS (mean ± S.D., N = 5) Time-to-% peak (s) 10% 50% 90% 100% CBF Control 0.9 ± 0.3 2.2 ± 0.6 5.2 ± 1.7 7.8 ± 1.8 Hypotension ----PO 2 Control 2.9 ± 0.2* 4.7 ± 0.6* 7.6 ± 1.9* 9.6 ± 2.6* Hypotension 2.1 ± 0.7 4.9 ± 0.6 7.9 ± 1.2 10.6 ± 1.5 OIS Control 2.4 ± 0.3* , ** 3.3 ± 0.5* , ** 6.2 ± 2.6** 7.2 ± 2.4** Hypotension 0.6 ± 0.4** 2.5 ± 1.3** 6.6 ± 2.2 9.1 ± 1.4** Significant differences (P b 0.05): * vs. CBF data, ** vs. PO 2 data. no significant differences were observed between the R-scores of the ∑LFP vs. CBF under control conditions (R mean = 0.78, p mean b 0.01) and the ∑LFP vs. OIS under hypotension conditions, as well as between ∑LFP vs. CBF under control conditions and the ∑LFP vs. PO 2 under hypotension conditions.
Discussion
The present study showed that the variability in the trial-bytrial CBF responses is well correlated with the variability in the trial-by-trial ∑LFP responses (Fig. 5A ). In addition, trial-by-trial variations in PO 2 and OIS under hypotension conditions strongly depended on the trial-by-trial ∑LFP variation (Figs. 5D and E) , indicating that the CMRO 2 responses are also strongly correlated with the ∑LFP. It was evident that the PO 2 and OIS changes under normal conditions closely depended on the ∑LFP (Figs. 5B and C). Since OIS represents deoxyhemoglobin-weighted signal changes, our findings support the notion that trial-by-trial variability in BOLD fMRI also represents the variability in neural responses in agreement with similar studies that have simultaneously measured EEG and fMRI. Further, our results indicate that the trial-by-trial variability in the neural activity can be determined by either neuro-vascular or neuro-metabolic measurements.
The trial-by-trial variation in ∑LFP can explain 63%, 45%, and 35% of the total variance in the LDF, PO 2 , and OIS measurements, respectively, under control conditions. Similarly, variations in PO 2 and OIS under hypotension conditions can be significantly explained by ∑LFP variations (61% and 60%, respectively). Another contributing source is the fluctuation of the baseline physiology (e.g., CBF). We observed slightly larger trial-by-trial variations in the hypotension experiments as compared to the control experiments; baseline variations in blood pressure (CV = 0.09 vs. 0.10), LDF (CV = 0.07 vs. 0.23), PO 2 (CV = 0.14 vs. 0.29), and OIS (CV = 0.012 vs. 0.014), in control vs. hypotension experiments, respectively. The larger baseline variation under the hypotension condition is mainly due to the timedependent vasodilator effects that produce slow drifts in the CBF baseline over the recording periods. Including a pre-stimulation LDF baseline value in the regression analysis slightly improved the trial-wise explained variations in LDF, PO 2 , and OIS under control conditions to 70%, 51%, and 47%, respectively. In summary, our data showed that the trial-by-trial variability in ∑LFP contributed over 50% to the variability in the amplitude of CBF (∼ 63%) and CMRO 2 (∼ 60%).
Under hypotension conditions, LFP activities were preserved even without CBF responses (Fig. 2B ). This finding shows that the neural activity-induced CBF response is not required to maintain activation-induced neural functions as performed in this study. We also observed that the tissue PO 2 under hypotension conditions never reached below hypoxic levels, which could potentially cause the depression of electrical neural activity (Foster et al., 2005 ). In preliminary experiments, preserved LFP activities were observed for 1-min-long stimulation periods under hypotension conditions (data not shown). Additionally, neural activity-induced CBF responses were observed to peak earlier than the apparent CMRO 2 changes (Fig. 3D ), suggesting that a tight control of the tissue PO 2 level is not likely to be a principal factor regulating CBF during functional activation under normal conditions. These findings support the notion that the quick response of CBF induced shortly after the onset of neural activation is not necessary to overcome the deficiency of oxygen during normal neural functions (Masamoto et al., 2007b) .
Since the change in PO 2 and OIS under hypotension conditions is directly related to the relative change in CMRO 2 , the impact of the physiologic changes in the CMRO 2 and CBF on each modality was determined. The ratio of the CMRO 2 to CBF impacts on the detected signal change was calculated to be 0.31 ± 0.09 and 0.40 ± 0.23 (N = 5) with respect to the PO 2 and OIS data, respectively, assuming that the CMRO 2 response was consistent under control and hypotension experiments (not normalized by ∑LFP). The ratio of the signal changes induced by CMRO 2 to CBF was calculated in previous experiments performed by our group in cats (Nagaoka et al., 2006) and similar results with respect to the present OIS data were obtained for BOLD fMRI data (~0.41). Other groups have reported the CMRO 2 /CBF coupling ratio induced by neural activity to be between 0.3 and 0.6 in anesthetized rats using optical imaging and fMRI (Mandeville et al., 1999; Liu et al., 2004) . The discrepancies in the reported values can be due to methodological variations and/or differences in physiologic controls.
Conclusions
The present study showed that variability in the activationinduced CMRO 2 and CBF changes can be used as a reliable index of trial-by-trial variability in neural activity. Although the amplitude of deoxyhemoglobin-weighted OIS, analogous to BOLD fMRI, was also observed to be sensitive to the variability in neural activity in individual trials, our results suggest that exclusive CBF or CMRO 2 -sensitive imaging methods would be more sensitive to the underlying neural activities.
